According to a report from NST on February 23rd, Malaysia has initiated over 100 investigations over the past two years into e-cigarette products allegedly containing illicit substances.
Malaysia's Deputy Health Minister Lukanisman Awang Sauni announced that with the passing of the "2024 Public Health Tobacco Control Act" (Act 852), all products related to cigarettes and e-cigarettes must be registered and labeled.
According to records, we launched 32 investigations in 2023, which increased to 90 in 2024. These investigations primarily targeted drugs and products containing substances related to drugs.
Last week, a state legislator called for action to curb adolescent addiction to "magic mushroom" e-cigarette products (related reading: Malaysia's e-cigarette sales go underground: online sales still rampant, brand searches are key). However, a deputy minister stated that no hallucinogenic compound psilocybin was found in the tested samples of "magic mushroom.
He added that they are strengthening law enforcement cooperation with relevant departments, including the police. Due to the increasingly complex sales methods, they are also monitoring on social media platforms.
Notice
1. This article is provided exclusively for professional research purposes related to industry, technology and policy. Any reference to brands or products is made solely for the purpose of objective description and does not constitute an endorsement, recommendation, or promotion of any brand or product.
2. The use of nicotine products, including but not limited to cigarettes, e-cigarettes, and heated tobacco products, is associated with significant health risks. Users are required to comply with all relevant laws and regulations in their respective jurisdictions.
3. This article is strictly restricted from being accessed or viewed by individuals under the legal age.
Copyright
This article is either an original work by 2Firsts or a reproduction from third-party sources with the original source clearly indicated. The copyright and usage rights of this article belong to 2Firsts or the original source. Unauthorized reproduction, distribution, or any other unauthorized use of this article by any entity or individual is strictly prohibited. Violators will be held legally responsible. For copyright-related matters, please contact: info@2firsts.com
AI Assistance Disclaimer
This article may have utilized AI to enhance translation and editing efficiency. However, due to technical limitations, errors may occur. Readers are advised to refer to the sources provided for more accurate information.
This article should not be used as a basis for any investment decisions or advice, and 2Firsts assumes no direct or indirect liability for any errors in the content.
